<code id='6BAC15131F'></code><style id='6BAC15131F'></style>
    • <acronym id='6BAC15131F'></acronym>
      <center id='6BAC15131F'><center id='6BAC15131F'><tfoot id='6BAC15131F'></tfoot></center><abbr id='6BAC15131F'><dir id='6BAC15131F'><tfoot id='6BAC15131F'></tfoot><noframes id='6BAC15131F'>

    • <optgroup id='6BAC15131F'><strike id='6BAC15131F'><sup id='6BAC15131F'></sup></strike><code id='6BAC15131F'></code></optgroup>
        1. <b id='6BAC15131F'><label id='6BAC15131F'><select id='6BAC15131F'><dt id='6BAC15131F'><span id='6BAC15131F'></span></dt></select></label></b><u id='6BAC15131F'></u>
          <i id='6BAC15131F'><strike id='6BAC15131F'><tt id='6BAC15131F'><pre id='6BAC15131F'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:8554
          CDC campus exterior -- first opinion coverage from STAT
          ACIP, normally a 15-member panel, has eight vacancies, and four more coming soon. Why hasn't HHS signed off on the CDC's nominees? Adobe

          A critical government advisory committee charged with charting U.S. vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country.

          The Advisory Committee on Immunization Practices, which has in recent years been a 15-person panel, has eight vacancies — one of which dates back more than a year. The other seven members’ terms ended in July, though they were extended through the year because they had no replacements. There is no chairperson.

          advertisement

          Four of the seven remaining members are due to finish their terms at the end of June, a cumulative exodus of expertise that will create what followers of the ACIP’s work believe is an unprecedented level of inexperience on the committee. Historically, three or four new members have been appointed to four-year terms every July, ensuring the roster always includes a mix of seasoned and new members.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Biotech startup Celsius cuts 75% of staff ahead of first trial start
          Biotech startup Celsius cuts 75% of staff ahead of first trial start

          AdobeLaunchingyourfirstclinicaltrialisthetypeofannouncementmostbiotechexecutiveseagerlyanticipate,ho

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Albert Bourla of Pfizer: worst biopharma CEO of 2023

          HyacinthEmpinado/STATPfizeristhisyear’santi-EliLilly.IfDavidRicksisthebestbiopharmaCEOof2023,thenPfi